Seven Mile Advisory’s Boston Scientific BSX Stock Holding History

Seven Mile Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,420	Closed	-$326K	–	193
2025 Q4	$326K	Sell	3,420 -382	-10%	-$37.5K	0.06%	161
2025 Q3	$371K	Buy	3,802 +795	+26%	+$82.3K	0.06%	173
2025 Q2	$323K	Sell	3,007 -85	-3%	-$8.6K	0.19%	109
2025 Q1	$312K	Buy	3,092 +40	+1%	+$4.03K	0.21%	106
2024 Q4	$273K	Buy	3,052 +35	+1%	+$3.08K	0.17%	111
2024 Q3	$253K	Buy	+3,017	New	+$238K	0.17%	125

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Seven Mile Advisory's BSX Position: Q1 2026 in Review

Seven Mile Advisory sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,420 shares — an estimated $326K sold.

Seven Mile Advisory first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $371K in Q3 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Seven Mile Advisory reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Seven Mile Advisory sold 3,420 Boston Scientific shares in Q1 2026, an estimated $326K.
Seven Mile Advisory first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
Seven Mile Advisory's Boston Scientific position peaked at $371K in Q3 2025.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.